OBJECTIVE: This study aimed to develop and validate a bespoke national hospital pharmacy competency framework for Austria that supports the hospital pharmacy workforce development.
METHODS: A multi-method study was carried out in three phases. (I) A systematic literature review across 48 websites of healthcare-related associations and six scientific databases was conducted, identifying competency frameworks, guidelines and related documents. (II) Extracted behaviour competencies were reviewed for contextual national appropriateness by three researchers prior to mapping against the \"Patient Care and Clinical Pharmacy Skills\" domain of European Common Training Framework (CTF). (III) Validation of the resultant draft clinical skills competency framework took place by an expert panel (n = 4; Austrian Association of Hospital Pharmacists (AAHP) board members) discussion. Reporting of findings is aligned with the recommendations for reporting Competency Framework Development in health professions (CONFERD-HP guidelines) and the PRISMA 2020 checklist.
RESULTS: The systematic review (SR) resulted in 28 frameworks, guidelines and related documents and the identification of 379 behaviour competencies, with nineteen mapped to the \"Patient Care and Clinical Pharmacy Skills\" domain of the CTF (after removal of duplicates). Expert panel discussion resulted in suggested changes to ensure contextual national appropriateness.
CONCLUSIONS: This study resulted in the development and validation of the first clinical national pharmacy competency framework for Austria. Future studies should focus on political and practical structures necessary for its successful implementation.
目的:本研究旨在开发和验证奥地利定制的国家医院药房能力框架,以支持医院药房劳动力的发展。
方法:分三个阶段进行了多方法研究。(I)对48个医疗保健相关协会网站和6个科学数据库进行了系统的文献综述,确定能力框架,指南和相关文件。(II)在针对欧洲共同培训框架(CTF)的“患者护理和临床药学技能”领域进行映射之前,由三名研究人员审查了提取的行为能力的背景国家适用性。(III)专家小组(n=4;奥地利医院药剂师协会(AAHP)董事会成员)讨论了对由此产生的临床技能能力框架草案的验证。调查结果的报告与报告卫生专业能力框架发展的建议(CONFERD-HP指南)和PRISMA2020清单一致。
结果:系统评价(SR)产生了28个框架,准则和相关文件,以及379项行为能力的识别,其中19个映射到CTF的“患者护理和临床药学技能”域(删除重复项之后)。专家小组讨论导致了建议的变化,以确保背景国家适当性。
结论:这项研究导致了奥地利第一个临床国家药学能力框架的开发和验证。未来的研究应侧重于成功实施该计划所需的政治和实践结构。